Have all the ICD primary prevention trials excluded an important group of patients?

Islam Bolad1, David T Martin

  • 1The Cardiac Arrhythmia Service, Lahey Medical Center, Burlington, Massachusetts 01805, USA.

Insights

Implantable cardioverter defibrillator (ICD) therapy may benefit patients with ventricular dysfunction after revascularization. Early ICD use in selected patients with perioperative ventricular arrhythmia is suggested pending further trials.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Primary prevention trials for implantable cardioverter defibrillator (ICD) therapy typically exclude patients early post-revascularization.
  • Clinicians frequently encounter patients with ventricular dysfunction and nonsustained ventricular tachyarrhythmia shortly after revascularization.
  • Current management lacks evidence-based guidelines, relying on clinician discretion.

Discussion:

  • Emerging evidence suggests this patient population faces an elevated risk of life-threatening ventricular tachyarrhythmia.
  • The study proposes considering ICD therapy for carefully selected patients experiencing perioperative ventricular arrhythmia.
  • This recommendation is made pending the results of prospective clinical trials.

Key Insights:

  • Patients with ventricular dysfunction post-revascularization are at high risk for serious arrhythmias.
  • Implantable cardioverter defibrillators (ICDs) are a potential therapeutic option for this group.
  • Evidence-based guidelines are needed for managing these complex cardiac patients.

Outlook:

  • Prospective trials are crucial to establish definitive guidelines for ICD use in this population.
  • Further research will clarify the long-term efficacy and safety of ICDs in early post-revascularization patients.
  • Optimizing patient selection for ICD therapy remains a key focus for future studies.

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...